Home > Press > Harris & Harris Group Invests in Solazyme
Harris & Harris Group, Inc., announced today that it has made a follow-on investment of $500,000 in Solazyme, Inc., ( http://www.solazyme.com ), as part of a Series B round financing comprising both equity and debt. The financing was led by the Roda Group and included undisclosed individual and institutional investors and Harris & Harris Group.
Harris & Harris Group Invests in Solazyme
New York, NY | Posted on March 7th, 2007
Founded in 2003, Solazyme is devoted to harnessing the energy-harvesting machinery of various species of algae to produce valuable products. The Company utilizes proprietary genetic engineering methods to develop and optimize commercially relevant biochemical pathways for production of biofuels and health and wellness materials.
About Harris & Harris Group
Detailed information about Harris & Harris Group and its holdings can be found on its website at www.TinyTechVC.com.
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Registration Statement on Form N-2 and Annual Report on Form 10-K for the year ended December 31, 2005, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the websites http://www.TinyTechVC.com and www.solazyme.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.
For more information, please click here
Harris & Harris Group, Inc.
Douglas W. Jamison
Copyright © Harris & Harris Group
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
Arrowhead Issues Open Letter to Shareholders October 9th, 2014
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Production of Biocompatible Polymers in Iran October 30th, 2014
Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014
Microrockets fueled by water neutralize chemical and biological warfare agents October 29th, 2014
Nanosafety research – there’s room for improvement October 29th, 2014
New solar power material converts 90 percent of captured light into heat: SunShot Project aims to make solar cost competitive October 29th, 2014
New Compact SIMS at 61st AVS | Visit us on Booth 311 October 28th, 2014
New evidence for an exotic, predicted superconducting state October 27th, 2014
Nanoparticle technology triples the production of biogas October 23rd, 2014